EPTIS
BAM Logo

HLA Diagnostics 06 – HLA Antibody Screening and Identification (445)

[HLA-Diagnostik 06 - HLA-Antikörper-Nachweis und -Spezifizierung (445)]

EPTIS Ringversuch Nr. 160453 | Letze Änderung 2023-10-23 | URL: https://www.eptis.bam.de/pts160453 https://www.eptis.bam.de/pts160453

Name des Anbieters
Name des Anbieters INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Ansässig in Germany
Sprache(n) German, English
Anmerkungen The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of three reference institutions appointed by the German Medical Association and, thus, responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results as PDF via https://rv-online.instandev.de. This price applies exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors.
Klassifizierung
Produktgruppen Human test material
Prüfgebiete Medical analysis
Technische Einzelheiten
Prüfobjekt Prüfeigenschaft Prüfmethode
5 Samples of Human serum, 1 ml each HLA antibody detection by CDC without DTT -
HLA antibody detection by CDC with DTT -
HLA antibody detection by SPA class I -
HLA antibody detection by SPA class II -
HLA-antibody specification by CDC: HLA-A -
HLA-antibody specification by CDC: HLA-B -
HLA-antibody specification by CDC: HLA-Cw -
HLA-antibody specification by SPA class I: HLA-A -
HLA-antibody specification by SPA class I: HLA-B -
HLA-antibody specification by SPA class I: HLA-Cw -
HLA-antibody specification by SPA class II: HLA-DRB -
HLA-antibody specification by SPA class II: HLA-DRB3/4/5 -
HLA-antibody specification by SPA class II: HLA-DQA -
HLA-antibody specification by SPA class II: HLA-DPB -
HLA-antibody specification by SPA class II: HLA-DPA -
HLA-antibody specification by complement-binding assay class I: HLA-A -
HLA-antibody specification by complement-binding assay class I: HLA-B -
HLA-antibody specification by complement-binding assay class I: HLA-Cw -
HLA-antibody specification by complement-binding assay class II: HLA-DRB -
HLA-antibody specification by complement-binding assay class II: HLA-DRB3/4/5 -
HLA-antibody specification by complement-binding assay class II: HLA-DQB -
HLA-antibody specification by complement-binding assay class II: HLA-DQA -
HLA-antibody specification by complement-binding assay class II: HLA-DPB -
HLA-antibody specification by complement-binding assay class II: HLA-DPA -
Ringversuchsziele
Zielgruppe des Ringversuchs
Relevante Rechtsvorschriften oder Normen
Weitere Ziele
Teilnehmerzahl <50
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt)

Akkreditiert durch DAkkS (Germany) auf der Grundlage von ISO/IEC 17043

German Bundesärztekammer (General medical Council)

Die Durchführung des Ringversuchs ist in Auftrag gegeben durch
Kosten
Teilnahmegebühr 272 Euro
Regelmässig durchgeführt Ja (2 times per year)
Der Ringversuch wird durchgeführt seit Experience with operation of ILCs since 1968
Kontaktdaten des Anbieters
Anbieter Kontaktperson
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Telefon: +49-211-159213-0
Fax:
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Weiss
Telefon: +49-211-159213430
Fax:
E-Mail: weiss@instand-ev.de weiss@instand-ev.de
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5